Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2009 May 30;132(20):772-8.
doi: 10.1016/j.medcli.2008.05.024. Epub 2009 May 22.

[Effect of pentoxifylline on the evolution of diabetic nephropathy]

[Article in Spanish]
Rafael Leyva-Jiménez  1 , Alaín R Rodríguez-Orozco, Luz Elena Ortega-Pierres, Jesús Ramírez-Enríquez, Anel Gómez-García, Cleto Alvarez-Aguilar
Affiliations
Randomized Controlled Trial

[Effect of pentoxifylline on the evolution of diabetic nephropathy]

[Article in Spanish]
Rafael Leyva-Jiménez et al. Med Clin (Barc). .

Abstract

Background and objective: Diabetic nephropathy (DN) is the principal cause of end-chronic kidney disease. Metabolic and hemodynamic components are directly involved. However, convincing data have shown that inflammation participates in the diabetic complications. The aim of this study was to investigate whether the inhibition of the inflammation and pro-inflammatory cytokines with pentoxifylline (PXF) attenuate the progression of the DN.

Subjects and method: In a prospective, randomized, double-blind, placebo- controlled study, we evaluated the effect of PXF (1200 mg daily) during 12 months, in 34 patients with incipient or established DN. Evaluated parameters were inflammation, pro-inflammatory cytokines and urinary albumin excretion (UAE).

Results: PXF treatment had a reno-protective effect determined by a significant reduction in the UAE in both incipient and established (p<0,01) DN patient. This effect was attributed to a reduction in the C-reactive protein, interleukin-6, tumor necrosis factor-alpha and leptin serum levels (p<0,01).

Conclusions: PXF treatment caused regression and prevented the progression of renal damage. Thus, PXF should be used in the preventive treatment of DN. These results showed that inflammation and pro-inflammatory cytokines are related to the progression of diabetic nephropathy.

PubMed Disclaimer

Publication types

Substances